Clinical trial
Is The Combine Prolotherapy More Effective Than The Traditional Prolotherapy In Patients With Temporomandibular Joint Hypermobility?
NCT07020455 is registered in ClinicalTrials.gov with Karadeniz Technical University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Is The Combine Prolotherapy More Effective Than The Traditional Prolotherapy In Patients With Temporomandibular Joint Hypermobility?
- Lead sponsor
- Karadeniz Technical University
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- January 1, 2019
- Completion date
- January 1, 2025
- Enrollment
- 26 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
arthrocentesis, hypermobility syndrome (disorder), hypermobility, joint, prolotherapy, temporomandibular disorders (tmd), temporomandibular pain